Elevance Health Q1 2024 Earnings Report
Key Takeaways
Elevance Health reported a 0.9% increase in operating revenue to $42.3 billion for Q1 2024, with diluted EPS up 15.5% to $9.59 and adjusted diluted EPS up 12.5% to $10.64. The company has raised its full-year earnings guidance and is launching a strategic partnership to advance primary care and physician enablement.
Operating revenue increased by 0.9% to $42.3 billion in Q1 2024.
Diluted EPS increased by 15.5% to $9.59, and adjusted diluted EPS increased by 12.5% to $10.64.
Full year diluted EPS and adjusted diluted EPS guidance were raised to greater than $34.05 and $37.20, respectively.
A strategic partnership was launched to advance primary care and physician enablement.
Elevance Health
Elevance Health
Forward Guidance
Elevance Health expects net income per diluted share to be greater than $34.05 in 2024 and adjusted diluted net income per share to be greater than $37.20.
Positive Outlook
- Increased outlook for full year earnings.
- Strategic partnership to advance primary care and physician enablement.
- Growth in Carelon's capabilities.
- Disciplined execution of strategic initiatives.
- Solid start to the year.